US 11191750
Use of mTOR inhibitors for treatment of familial adenomatous polyposis
granted A61KA61K31/192A61K31/415
Quick answer
US patent 11191750 (Use of mTOR inhibitors for treatment of familial adenomatous polyposis) held by The Board of Regents of the University of Texas System expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/192, A61K31/415, A61K31/436, A61K45/06